144 related articles for article (PubMed ID: 38485866)
1. ASO Author Reflections: The Role of Neoadjuvant Chemotherapy in Invasive Intraductal Mucinous Neoplasms of the Pancreas.
Fogliati A; Truty MJ
Ann Surg Oncol; 2024 May; 31(5):2967-2968. PubMed ID: 38485866
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.
Redegalli M; Schiavo Lena M
Ann Surg Oncol; 2022 Jun; 29(6):3503. PubMed ID: 35187623
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma-Predictors of Disease Progression and Performance Status Decline.
Paniccia A; Zureikat A
Ann Surg Oncol; 2020 Aug; 27(8):2972-2973. PubMed ID: 32124127
[No Abstract] [Full Text] [Related]
4. [Combination of intraductal papillary mucinous neoplasm with other cystic pancreatic tumors].
Panteleev VI; Kaldarov AR; Gorin DS; Kriger AG
Khirurgiia (Mosk); 2021; (2):80-83. PubMed ID: 33570359
[TBL] [Abstract][Full Text] [Related]
5. How to do an enucleation of a branch-duct intraductal papillary and mucinous neoplasm of the head of the pancreas (with video).
de Carbonnières A; Belle A; Gaujoux S
ANZ J Surg; 2023 Apr; 93(4):1021-1023. PubMed ID: 36881471
[TBL] [Abstract][Full Text] [Related]
6. One of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.
Hata T; Sakata N; Motoi F; Unno M
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23420728
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic intraductal papillary mucinous neoplasm with concomitant heterotopic pancreatic cystic neoplasia of the stomach: a case report and review of the literature.
Tsapralis D; Charalabopoulos A; Karamitopoulou E; Schizas D; Charalabopoulos K; Liakakos T; Macheras A
Diagn Pathol; 2010 Jan; 5():4. PubMed ID: 20205774
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of cystic neoplasms of the pancreas and their surgical management.
Sheehan MK; Beck K; Pickleman J; Aranha GV
Arch Surg; 2003 Jun; 138(6):657-60; discussion 660-2. PubMed ID: 12799338
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution?
Salvia R; Malleo G; Maggino L; Milella M; Bassi C
Updates Surg; 2020 Jun; 72(2):321-324. PubMed ID: 32445032
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Spatial Immunophenotyping of Intraductal Papillary Mucinous Neoplasm.
Eckhoff A; Allen PJ
Ann Surg Oncol; 2022 Nov; 29(12):7789-7790. PubMed ID: 35835928
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy Changes Body Composition Influencing Long-term Outcomes.
Takaichi S; Tomimaru Y; Kobayashi S; Toya K; Sasaki K; Iwagami Y; Yamada D; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
Ann Surg Oncol; 2023 Apr; 30(4):2469-2470. PubMed ID: 36567385
[No Abstract] [Full Text] [Related]
12. [Cystic and intraductal tumors of the pancreas].
Le Borgne J
Rev Prat; 2002 Sep; 52(14):1540-5. PubMed ID: 12412301
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
[TBL] [Abstract][Full Text] [Related]
14. ASO Author Reflections: Surgery for Intraductal Papillary Mucinous Neoplasm: Predicting Risk for Better Patient Selection.
Perri G; Marchegiani G; Salvia R
Ann Surg Oncol; 2022 May; 29(5):3215-3216. PubMed ID: 35157193
[No Abstract] [Full Text] [Related]
15. Laparoscopic resection of synchronous intraductal papillary mucinous neoplasms: a case report.
Xu XW; Li RH; Zhou W; Wang J; Zhang RC; Chen K; Mou YP
World J Gastroenterol; 2012 Nov; 18(44):6510-4. PubMed ID: 23197900
[TBL] [Abstract][Full Text] [Related]
16. Upfront resection of pancreatic intraductal neoplasms.
Gourd E
Lancet Oncol; 2018 Jan; 19(1):e14. PubMed ID: 29198473
[No Abstract] [Full Text] [Related]
17. [Duodenum-preserving total pancreatic head resection : an organ-sparing operation technique for cystic neoplasms and non-invasive malignant tumors].
Beger HG; Siech M; Poch B
Chirurg; 2013 May; 84(5):412-20. PubMed ID: 23417612
[TBL] [Abstract][Full Text] [Related]
18. ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma.
Murthy P; Boone BA
Ann Surg Oncol; 2020 Mar; 27(3):907-908. PubMed ID: 31823171
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms.
Al Efishat M; Allen PJ
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):822-823. PubMed ID: 30324467
[No Abstract] [Full Text] [Related]
20. Clinical characteristics and survival prediction of surgical patients with invasive pancreatic cystic neoplasm: a large retrospective study over two decades.
Song Y; Li Z; Cui H; Xu J; Song J
World J Surg Oncol; 2023 Aug; 21(1):261. PubMed ID: 37612715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
